Keyphrases
Pancreatic Ductal Adenocarcinoma
100%
Type 1 Diabetes Mellitus (T1DM)
100%
African American
100%
Non-Hispanic White
100%
White Americans
100%
Metformin Use
100%
US Veterans
100%
Pancreatic Cancer Survival
100%
Confidence Interval
85%
African American Patients
57%
Overall Survival
42%
Metformin
42%
Metastatic Disease
42%
Survival Benefit
28%
White Patients
28%
Nave
28%
Veterans Health Administration
28%
Cox Proportional Hazards Regression
14%
Non-associated
14%
Multivariable
14%
Adjunctive Therapy
14%
United States Veterans
14%
Gestational Diabetes Mellitus
14%
Immortal Time Bias
14%
Population-based Retrospective Cohort Study
14%
Complete Analysis
14%
Medicine and Dentistry
Glycon
100%
Diabetes Mellitus
100%
Pancreas Cancer
100%
Pancreas Adenocarcinoma
87%
Metastatic Carcinoma
37%
Overall Survival
37%
Veterans Health
25%
Retrospective Cohort Study
12%
Proportional Hazards Model
12%
Agricultural and Biological Sciences
Americans
100%
Confidence Interval
100%
African
100%
Veterans
100%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
Cancer Survival
100%
Veterans Health
66%
Cohort Study
33%